September 27, 2024 03:11 PM EDT

US government renews threats over J&J's proposed 340B rebate model

Nicole DeFeudis

Editor

The federal government renewed its threats to Johnson & Johnson on Friday over the company’s proposal to change how some hospitals receive drug price discounts …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

US government renews threats over J&J's proposed 340B rebate model

Nicole DeFeudis

Editor

Sign up to read this article for free.

Sr. Manager/Associate Director, Document Control

Viridian Therapeutics

Waltham, MA, USA

The Endpoints 11 winners: Big bets on AI, new frontiers in editing, a neuro renaissance and Chinese chemistry

FDA approves Dupixent in COPD, opening ‘next chapter’ for Sanofi and Regeneron’s bestseller

Steve Davis leaves Acadia, replaced by Bristol Myers alum; Former J&J exec to lead R&D at Novavax

FDA approves Bristol Myers and Karuna's schizophrenia drug, in milestone for psychiatry

Novo Nordisk to decrease some insulin pen manufacturing, transition supply

PDCs vs. ADCs: A New Frontier in Targeted Cancer Therapies and the Potential for Development Partnerships

US gov­ern­ment re­news threats over J&J's pro­posed 340B re­bate mod­el

Editor

Sign up to read this article for free.

Viridian Therapeutics

Waltham, MA, USA

US government renews threats over J&J's proposed 340B rebate model